PNF Versus Conventional Exercise in Sarcopenia
Comparative Effects of Proprioceptive Neuromuscular Facilitation and Conventional Exercise on Balance, Mobility, and Fall-Related Outcomes in Older Adults With Sarcopenia
1 other identifier
interventional
34
1 country
2
Brief Summary
Sarcopenia is an age-related skeletal muscle disorder characterized by reduced muscle strength, muscle mass, and physical performance. It may lead to impaired balance, reduced mobility, falls, loss of independence, and reduced quality of life. Exercise is a central component of sarcopenia management; however, the additional effects of proprioceptive neuromuscular facilitation exercises in older adults with sarcopenia remain unclear. This study compared proprioceptive neuromuscular facilitation-based exercise with conventional exercise in adults aged 65 years or older with sarcopenia. A total of 34 participants were assigned to either a proprioceptive neuromuscular facilitation group or a conventional exercise group. Both groups participated in supervised exercise sessions three times per week for 10 weeks, with each session lasting approximately 45 minutes. The conventional exercise program included lower-extremity strengthening, balance, functional mobility, sit-to-stand, gait, and stretching exercises. The proprioceptive neuromuscular facilitation group received the conventional exercise program together with proprioceptive neuromuscular facilitation techniques. Participants were evaluated at baseline, during the first month, and during the third month after initiation of the exercise program. Outcomes included balance, functional mobility, walking capacity, lower-extremity functional performance, stair performance, fear of falling, and depressive symptoms. Assessments included the Berg Balance Scale, Timed Up and Go Test, 6-Minute Walk Test, Five Times Sit-to-Stand Test, stair ascent and descent test, Tinetti Falls Efficacy Scale, and Geriatric Depression Scale.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2022
Shorter than P25 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 12, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 15, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2022
CompletedFirst Submitted
Initial submission to the registry
July 28, 2026
CompletedFirst Posted
Study publicly available on registry
August 3, 2026
CompletedAugust 3, 2026
July 1, 2026
5 months
July 28, 2026
July 28, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Berg Balance Scale score
Balance function was assessed using the Berg Balance Scale. Scores were measured at baseline, at the first-month assessment, and at the third-month assessment after initiation of the exercise program. Changes over time and differences between the groups were analyzed.
Time Frame: Baseline, 1 month, and 3 months after initiation of the intervention
Secondary Outcomes (6)
Change in Tinetti Falls Efficacy Scale score
Baseline, 1 month, and 3 months after initiation of the intervention
Change in Timed Up and Go Test performance
Time Frame: Baseline, 1 month, and 3 months after initiation of the intervention
Change in 6-Minute Walk Test distance
Time Frame: Baseline, 1 month, and 3 months after initiation of the intervention
Change in Five Times Sit-to-Stand Test time
Time Frame: Baseline, 1 month, and 3 months after initiation of the intervention
Change in stair ascent and descent test time
Time Frame: Baseline, 1 month, and 3 months after initiation of the intervention
- +1 more secondary outcomes
Study Arms (2)
ARM 1 / Conventional Exercise Group
ACTIVE COMPARATORParticipants in this group received a supervised conventional exercise program including lower-extremity strengthening, balance training, functional mobility exercises, sit-to-stand practice, gait exercises, and stretching. The exercise program was performed three days per week for 10 consecutive weeks, with each session lasting approximately 45 minutes. Exercise intensity and progression were individually adjusted according to each participant's functional capacity and clinical tolerance.
ARM 2/Conventional Exercise Plus PNF Group
EXPERIMENTALParticipants in this group received the same supervised conventional exercise program together with proprioceptive neuromuscular facilitation exercises. The PNF intervention included diagonal movement patterns, proprioceptive stimulation, coordinated neuromuscular activation, manual resistance, and task-oriented functional movement patterns. The combined exercise program was performed three days per week for 10 consecutive weeks, with each session lasting approximately 45 minutes. Exercise intensity and progression were individually adjusted according to each participant's functional capacity and clinical tolerance.
Interventions
Participants received a supervised conventional exercise program including lower-extremity strengthening, balance training, functional mobility exercises, sit-to-stand practice, gait exercises, and stretching. The program was performed three days per week for 10 consecutive weeks, with each session lasting approximately 45 minutes. Exercise intensity and progression were individualized according to functional capacity and clinical tolerance.
Participants received proprioceptive neuromuscular facilitation exercises in addition to the conventional exercise program. The PNF intervention included diagonal movement patterns, proprioceptive stimulation, coordinated neuromuscular activation, manual resistance, and task-oriented functional movement patterns designed to improve postural control, balance, gait, and lower-extremity functional performance. The combined program was performed three days per week for 10 consecutive weeks, with each session lasting approximately 45 minutes.
Eligibility Criteria
You may qualify if:
- Adults aged 65 years or older.
- Diagnosis of sarcopenia according to the European Working Group on Sarcopenia in Older People criteria.
- Ability to participate safely in the prescribed exercise program.
- Completion of the baseline clinical assessment.
- Provision of written informed consent to participate in the study.
You may not qualify if:
- Parkinson's disease.
- Previous stroke.
- Multiple sclerosis.
- Vestibular disorders or vertigo.
- Other major neurological diseases that could affect balance, gait, mobility, or physical performance.
- Severe musculoskeletal disorders that could independently affect balance, gait, mobility, or participation in exercise.
- Uncontrolled cardiovascular disease.
- Any medical condition that could preclude safe participation in the exercise program.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Uşak Universitylead
Study Sites (2)
Facility Name: Uşak Training and Research Hospital
Uşak, Uşak, 64100, Turkey (Türkiye)
Usak Training and Research Hospital, Physical Medicine and Rehabilitation Clinic
Uşak, Turkey (Türkiye)
Related Publications (1)
• Pereira MP, Gonc¸alves M Proprioceptive Neuromuscular Facilitation Improves Balance and Knee Extensors Strength of Older Fallers. International Scholarly Research Network ISRN Rehabilitation. Volume 2012, Article ID 402612, 7 pages
BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
July 28, 2026
First Posted
August 3, 2026
Study Start
February 12, 2022
Primary Completion
July 15, 2022
Study Completion
August 1, 2022
Last Updated
August 3, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared because the ethics approval and informed consent documents did not include permission for external sharing of individual-level data. Aggregate study results may be made available from the corresponding investigator upon reasonable request, subject to institutional and ethical regulations.